<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32219644</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1534-6307</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
              <Day>26</Day>
            </PubDate>
          </JournalIssue>
          <Title>Current rheumatology reports</Title>
          <ISOAbbreviation>Curr Rheumatol Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy.</ArticleTitle>
        <Pagination>
          <StartPage>11</StartPage>
          <MedlinePgn>11</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11926-020-0885-y</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE OF REVIEW">The aim of this review is to provide the information necessary for recognizing scleritis in rheumatology patients, recognize associated systemic diseases in scleritis patients referred to rheumatology, and choose the best conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) or biologic therapy, based on the most recent data.</AbstractText>
          <AbstractText Label="RECENT FINDINGS">Scleritis is most often associated with systemic conditions, particularly autoimmune conditions. Rheumatologists should be most vigilant about rheumatoid arthritis and ANCA-associated vasculitis. A recent systemic association has been found with IgG4-related disease as well. Most of the therapeutic decisions are based on observational data. Most recently, there is increasing evidence of the role of rituximab for refractory disease. Scleritis is a severe inflammatory ocular condition that leads to complications including vision loss. It can precede a systemic autoimmune disease diagnosis, especially in the case of vasculitis. Prompt recognition and adequate therapy are needed in order to avoid serious ocular complications. There is an unmet need for (1) head-to-heat trials on csDMARDs and biologic drugs for the treatment of idiopathic scleritis and (2) randomized controlled trials on the treatment of refractory cases.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Nevares</LastName>
            <ForeName>Alana</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology and Clinical Immunology, College of Medicine at the University of Vermont Medical Center, 111 Colchester Avenue, Burlington, VT, 05401, USA. Alana.Nevares@uvmhealth.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raut</LastName>
            <ForeName>Robert</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Ophthalmology, The University of Vermont Medical Center, Burlington, VT, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Libman</LastName>
            <ForeName>Bonita</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Rheumatology and Clinical Immunology, College of Medicine at the University of Vermont Medical Center, Burlington, VT, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hajj-Ali</LastName>
            <ForeName>Rula</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Cleveland Clinic Lerner College of Medicine, Department of Rheumatic and Immunologic Diseases, Orthopaedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>03</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Curr Rheumatol Rep</MedlineTA>
        <NlmUniqueID>100888970</NlmUniqueID>
        <ISSNLinking>1523-3774</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>4F4X42SYQ6</RegistryNumber>
          <NameOfSubstance UI="D000069283">Rituximab</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000069283" MajorTopicYN="N">Rituximab</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015423" MajorTopicYN="Y">Scleritis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Autoimmune</Keyword>
        <Keyword MajorTopicYN="Y">Scleritis</Keyword>
        <Keyword MajorTopicYN="Y">Systemic associations</Keyword>
        <Keyword MajorTopicYN="Y">Treatment</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32219644</ArticleId>
        <ArticleId IdType="doi">10.1007/s11926-020-0885-y</ArticleId>
        <ArticleId IdType="pii">10.1007/s11926-020-0885-y</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Am J Ophthalmol. 2016 Dec;172:104-110</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27663070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graefes Arch Clin Exp Ophthalmol. 2005 Apr;243(4):374-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15864626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 2009 Nov;116(11):2188-98.e1</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19748676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Med. 1977 Jul;63(1):131-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">327802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ocul Immunol Inflamm. 2017 Jun;25(3):405-412</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27003323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Intern Med. 1992 Mar 15;116(6):488-98</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1739240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 2010 Feb;117(2):356-65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19969366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Ophthalmol. 2016 Aug;100(8):1062-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26567022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 1995 Apr;102(4):687-92</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7724185</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Ophthalmol. 1976 Mar;60(3):163-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1268179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cornea. 2013 Dec;32(12):1562-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24145628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 1994 Jul;101(7):1281-6; discussion 1287-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8035992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Ophthalmol. 2010 Mar;149(3):423-32.e1-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20042178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acta Ophthalmol. 2016 Sep;94(6):e400-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27010181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acta Ophthalmol. 2017 Dec;95(8):e795-e796</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28229544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Ophthalmol. 2010 May;94(5):579-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19955205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Pathol. 2019 May;72(5):386-390</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30723093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ocul Immunol Inflamm. 2019;27(3):389-395</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29023165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 2014 Dec;121(12):2340-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25097155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 2012 Jan;119(1):43-50</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21963265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>CMAJ. 2012 May 15;184(8):E431-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22470169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rheumatology (Oxford). 2017 Oct 1;56(10):1763-1770</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28957561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 2004 Mar;111(3):501-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15019326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jpn J Ophthalmol. 1992;36(4):452-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1289622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ocul Immunol Inflamm. 2004 Jun;12(2):143-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15512984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 2005 Oct;112(10):1814-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16199269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 2014 Oct;121(10):1885-91</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24953794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Rheumatol. 2018 May;45(5):595-603</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29449499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Ocul Biol Dis Infor. 2009 Dec 12;3(1):12-19</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20835396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Ophthalmol. 2016 Sep;100(9):1290-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26888976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Ophthalmol. 2005 Jun;89(6):775-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15923522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ocul Immunol Inflamm. 2014 Aug;22(4):311-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24724703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ann Rheum Dis. 1989 Jan;48(1):7-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2923507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 1999 Jul;106(7):1328-33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10406616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 1995 May;102(5):718-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7777270</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Rheumatol. 2012 Feb;39(2):233-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22174213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ocul Immunol Inflamm. 2018;26(6):915-920</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28537473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Ophthalmol. 2013 Oct;156(4):752-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23891336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ocul Immunol Inflamm. 2012 Oct;20(5):375-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23030356</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 2014 Mar;121(3):785-96.e3</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24359625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Rheumatol. 2008 Apr;27(4):503-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18097711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Indian J Gastroenterol. 2015 Sep;34(5):387-94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26614005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Ophthalmol. 2016 Apr;164:22-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26766304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmology. 1984 Oct;91(10):1253-63</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6514289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmic Epidemiol. 2008 Jan-Feb;15(1):47-55</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18300089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Ophthalmol. 2000 Oct;130(4):469-76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11024419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Ophthalmol. 2009 Oct;148(4):500-509.e2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19570522</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joint Bone Spine. 2019 Nov;86(6):699-705</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30711694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ophthalmic Plast Reconstr Surg. 2017 Mar/Apr;33(2):e45-e47</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27262144</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Crohns Colitis. 2016 Apr;10(4):429-36</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26721936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Semin Arthritis Rheum. 2013 Apr;42(5):507-14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23270762</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>N Engl J Med. 2010 Jul 15;363(3):221-32</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20647199</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
